Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) |
| BNF code | 1001030Z0BBABAB |
| Virtual Medicinal Product | Belimumab 400mg powder for solution for infusion vials |
| Name | Benlysta 400mg powder for concentrate for solution for infusion vials |
| Abbreviated name | Benlysta 400mg pdr for concentrate for inf vials |
| Supplier | GlaxoSmithKline UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✓ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
| Actual Medicinal Product Packs | |
| Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_11.0.0_20251103000001, imported on 4th November 2025 at 04:00:10.